EssilorLuxottica (OTCMKTS:ESLOY) Trading Down 7.8% – Here’s What Happened

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY)’s share price traded down 7.8% during trading on Tuesday . The company traded as low as $140.93 and last traded at $141.3950. 225,897 shares traded hands during mid-day trading, an increase of 136% from the average session volume of 95,598 shares. The stock had previously closed at $153.35.

Wall Street Analysts Forecast Growth

ESLOY has been the subject of several recent research reports. HSBC upgraded shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Wednesday, January 14th. Kepler Capital Markets upgraded shares of EssilorLuxottica from a “hold” rating to a “buy” rating in a research note on Thursday, January 15th. Citigroup restated a “buy” rating on shares of EssilorLuxottica in a report on Thursday, December 11th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of EssilorLuxottica in a research report on Friday, December 5th. Finally, Royal Bank Of Canada reissued an “outperform” rating on shares of EssilorLuxottica in a research report on Tuesday, October 28th. Two research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy”.

EssilorLuxottica Trading Down 1.3%

The stock’s 50-day simple moving average is $156.64 and its 200-day simple moving average is $163.20. The company has a current ratio of 0.97, a quick ratio of 0.67 and a debt-to-equity ratio of 0.18.

EssilorLuxottica Company Profile

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.